news

Virocell launch on The Biomedical Scientist

Friday, 4 June 2021

Source: The Biomedical Scientist

VIRAL VECTORS

ViroCell Biologics, the UK’s first clinical trial-focused viral vector manufacturer, has officially launched. It aims to be the supplier of choice for viral vectors and gene-modified cells, to academic and corporate clients, for translational cell and gene therapies going into clinical trials. One of the founders of ViroCell is Farzin Farzaneh, Professor of Molecular Medicine at King’s College London, and it expects to employ more than 50 professionals in the UK by the end of 2021.

'The company is established for the public benefit to further such objects or purposes which are exclusively charitable according to the laws of England and Wales in any part of the world and in such manner as the trustees may in their absolute discretion think fit, in particular but not exclusively for purposes concerned with the conservation and protection of the environment’.

Company Registration number is 07893448, registered address is Vestry House, Laurence Pountney Hill, London EC4R 0EH, Charity number 1147994